Tahir Amin

Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For Decades

Tahir Amin, Aaron S. Kesselheim · Health Affairs · 2012 · 102 citations

Pharmaceutical Innovation, Law, Branded Pharmaceuticals +18

Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India

Swathi Padmanabhan, Tahir Amin, Bhaven N. Sampat et al. · Nature Biotechnology · 2010 · 51 citations · Full text

Law, Vaccine Hesitancy, Policy Analysis +24

Ethno-National Movements in Pakistan: Domestic and International Factors.

Lawrence Ziring, Tahir Amin · Pacific Affairs · 1989 · 51 citations

Culture, Nationalism, Education +5

A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness

Tahir Amin, Aaron S. Kesselheim · INQUIRY The Journal of Health Care Organization Provision and Financing · 2022 · 38 citations · Full text

Global Health Law, Vaccine Hesitancy, Ip Waiver +20

Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of developing country vaccine manufacturers

Subhashini Chandrasekharan, Tahir Amin, Joyce Kim et al. · Vaccine · 2015 · 22 citations · Full text

Law, Technology Law, Intellectual Property Rights +25